EurekaMag.com logo
+ Site Statistics
References:
54,215,046
Abstracts:
30,230,908
PMIDs:
28,215,208
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Recurrent CMV disease after ganciclovir treatment in kidney and kidney-pancreas transplant recipients



Recurrent CMV disease after ganciclovir treatment in kidney and kidney-pancreas transplant recipients



Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 714A, Sept




(PDF emailed within 1 workday: $29.90)

Accession: 033119093

Download citation: RISBibTeXText



Related references

Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients. Transplantation 67(1): 94-97, 1999

Improved patient survival in recipients of simultaneous pancreas-kidney transplant compared with kidney transplant alone in patients with type 1 diabetes mellitus and end-stage renal disease. British Journal of Surgery 90(9): 1137-1141, 2003

Renal pathology and clinical presentations of polyomavirus nephropathy in simultaneous kidney pancreas transplant recipients compared with kidney transplant recipients. Transplantation Proceedings 36(4): 1095-1096, 2004

Valganciclovir prophylaxis for cytomegalovirus disease in kidney and simultaneous pancreas-kidney transplant recipients. Journal of Urology 167(4 Supplement): 371, April, 2002

Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis. Transplant International 20(11): 974-981, 2007

Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone. Transplantation Proceedings 33(1-2): 1796-1798, 2001

Pancreas transplant options for patients with type 1 diabetes mellitus and chronic kidney disease: simultaneous pancreas kidney or pancreas after kidney?. Current Opinion in Organ Transplantation 17(1): 80-86, 2013

Efficacy of valganciclovir in the treatment of cytomegalovirus disease in kidney and pancreas transplant recipients. Transplantation Proceedings 38(10): 3673-3675, 2006

Kidney retransplantation following graft loss to polyoma virus-associated nephropathy: an effective treatment option in simultaneous pancreas and kidney transplant recipients. Transplant International 21(4): 353-356, 2008

Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis. Transplant Infectious Disease 3(1): 8-15, 2001

Reported isolated pancreas rejection is associated with poor kidney outcomes in recipients of a simultaneous pancreas kidney transplant. Transplantation 86(9): 1229-1233, 2008

Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience. Transplantation Proceedings 28(2): 995-997, 1996

The cardinal features of recurrent autoimmunity in simultaneous pancreas-kidney transplant recipients. Current Diabetes Reports 10(5): 321-322, 2010

Long-term treatment of chronic hepatitis B with oral ganciclovir in two kidney transplant recipients. Clinical Nephrology 50(6): 392-392, 1999

Treatment of cytomegalovirus infections with ganciclovir in kidney transplant recipients. Clinical and pharmacokinetic study. Presse Medicale 20(40): 2030-2032, 1991